Credit Suisse’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-23,704
| Closed | -$116K | – | 3746 |
|
|
2022
Q4 | $116K | Sell |
23,704
-1,273
| -5% | -$6.21K | ﹤0.01% | 3292 |
|
|
2022
Q3 | $360K | Buy |
24,977
+4,053
| +19% | +$58.4K | ﹤0.01% | 2974 |
|
|
2022
Q2 | $317K | Buy |
20,924
+1,659
| +9% | +$25.1K | ﹤0.01% | 3116 |
|
|
2022
Q1 | $228K | Buy |
19,265
+1,199
| +7% | +$14.2K | ﹤0.01% | 3323 |
|
|
2021
Q4 | $294K | Buy |
18,066
+1,124
| +7% | +$18.3K | ﹤0.01% | 3299 |
|
|
2021
Q3 | $483K | Buy |
16,942
+1,375
| +9% | +$39.2K | ﹤0.01% | 3009 |
|
|
2021
Q2 | $527K | Buy |
15,567
+851
| +6% | +$28.8K | ﹤0.01% | 2992 |
|
|
2021
Q1 | $445K | Sell |
14,716
-13,223
| -47% | -$400K | ﹤0.01% | 3018 |
|
|
2020
Q4 | $1.38M | Sell |
27,939
-1,537
| -5% | -$76.1K | ﹤0.01% | 2362 |
|
|
2020
Q3 | $1.13M | Sell |
29,476
-7,680
| -21% | -$295K | ﹤0.01% | 2185 |
|
|
2020
Q2 | $1.61M | Buy |
37,156
+15,982
| +75% | +$690K | ﹤0.01% | 2012 |
|
|
2020
Q1 | $553K | Sell |
21,174
-10,071
| -32% | -$263K | ﹤0.01% | 2468 |
|
|
2019
Q4 | $976K | Buy |
31,245
+21,830
| +232% | +$682K | ﹤0.01% | 2527 |
|
|
2019
Q3 | $246K | Buy |
+9,415
| New | +$246K | ﹤0.01% | 3119 |
|